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Gene duplication is one of the most important mechanisms for
creating new genes and generating genomic novelty. Retrotrans-
poson-mediated sequence transduction (i.e., the process by which
a retrotransposon carries flanking sequence during its mobiliza-
tion) has been proposed as a gene duplication mechanism. L1 exon
shuffling potential has been reported in cell culture assays, and
two potential L1-mediated exon shuffling events have been iden-
tified in the genome. SVA is the youngest retrotransposon family
in primates and is capable of 3 flanking sequence transduction
during retrotransposition. In this study, we examined all of the
full-length SVA elements in the human genome to assess the
frequency and impact of SVA-mediated 3 sequence transduction.
Our results showed that 53 kb of genomic sequences have been
duplicated by 143 different SVA-mediated transduction events. In
particular, we identified one group of SVA elements that dupli-
cated the entire AMAC gene three times in the human genome
through SVA-mediated transduction events, which happened be-
fore the divergence of humans and African great apes. In addition
to the original AMAC gene, the three transduced AMAC copies
contain intact ORFs in the human genome, and at least two are
actively transcribed in different human tissues. The duplication of
entire genes and the creation of previously undescribed gene
families through retrotransposon-mediated sequence transduction
represent an important mechanism by which mobile elements
impact their host genomes.
gene duplication  SVA  retrotransposition  mobile element
The emergence of new genes and biological functions is crucialto the evolution of species (1). Several mechanisms for
creating new genes are known (1), the best characterized path-
way being through duplication of preexisting genes (1, 2). Several
types of duplications leading to genetic innovation have been
investigated, including segmental duplication (3) and gene ret-
rotransposition (4–7). Here, we investigate a less well charac-
terized mechanism that can potentially duplicate genes, namely
the transduction of flanking genomic sequence associated with
the retrotransposition of mobile elements.
Retrotransposons usually do not carry downstream motifs that
are important for efficient transcription termination. Therefore,
when they are transcribed, the RNA transcription machinery
sometimes skips the element’s own weak polyadenylation signal
and terminates transcription by using a downstream polyadenyl-
ation site located in the 3 f lanking genomic sequence. The
transcript containing the retrotransposon along with the extra
genomic sequence is subsequently integrated back into the
genome through retrotransposition, a process termed 3 trans-
duction (8, 9). In principle, this mechanism could lead to the
duplication of coding sequences located in the transduced
flanking genomic sequence. Indeed, the exon shuffling and
genetic diversity of the L1-mediated 3 transduction has been
demonstrated in cell culture assays (9, 10). However, among all
of the studies investigating L1-mediated exon shuffling (11–16),
only two putative examples of exon transduction have been
reported in the human genome (15, 16).
The SVA family of retrotransposons originated 25 million
years ago (mya) and has increased to 3,000 copies in the human
genome (17, 18). Similar to L1 elements, SVA elements are
thought to be transcribed by RNA polymerase II and have the
ability to transduce downstream sequence (18). Approximately
10% of human SVA elements appear to have been involved in
sequence transduction events (17). Here, we examined the extent
and properties of SVA-mediated transduction events to evaluate
their evolutionary impact on the human genome. Our results
demonstrate that retrotransposon-mediated sequence transduc-
tion is not only a mechanism for exon shuffling but also serves
as a previously uncharacterized mechanism for gene duplication
and the creation of new gene families.
Results and Discussion
Genomic Analysis for SVA 3 Transductions. To investigate the extent
of transduction events associated with SVA elements, we exam-
ined all 1,752 full-length SVA elements in the human genome
reference sequence. In total, 143 SVA elements with putative
transduced sequences were identified according to our valida-
tion criteria (Fig. 1; see Materials and Methods for details). Most
of these loci (123 of 143) also displayed typical AATAAA or
ATTAAA polyadenylation signals located 5–52 nt upstream of
the start of the poly(A) tail, further supporting that these loci
represent authentic SVA-mediated transduction events. The size
of the transduced sequences ranged from 35 to 1,853 bp, with an
average of 340 bp (Fig. 2). Overall, 52,740 bp of genomic
sequences were duplicated by these SVA-mediated transduc-
tions. To determine whether the transduction events are specific
characteristics of particular SVA subfamilies, SVA elements
with transduced sequence were aligned and compared with all
known SVA subfamily consensus sequences (17). We found
transduction events involving all previously identified SVA
families, suggesting that 3 transduction is a common phenom-
enon among SVA members (see Table 1, which is published as
supporting information on the PNAS web site). Given that
full-length SVA elements comprise 63% of the family, we
extrapolate that SVA elements may have transduced a total of
84 kb of genomic sequence during their expansion.
The rate of SVA-mediated transduction events (8.2%) is
similar to the L1 transduction rates reported in previous studies
(11, 12, 14). Our results are likely to be an underestimate because
the method we used to validate candidate transductions relied on
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the detection of perfect target site duplications (TSDs). This
requirement may miss transduction events as a result of substi-
tutions in their TSDs. Detailed information concerning all of the
SVA transduction events reported in this article can be found in
Table 2, which is published as supporting information on the
PNAS web site.
Identification of Transduction Source Loci. To identify the source
loci of the transduced sequences, we searched the human
genome by using the BLAST-like alignment tool (BLAT)
(http:genome.ucsc.educgi-binhgBlat?commandstart).
With the exception of 19 loci in which the transduced sequence
was totally composed of repetitive sequences or source loci were
located in segmental duplications (Fig. 1) and, thus, could not be
mapped precisely to any location in the human genome, we were
able to identify the source loci for each of the other 124
transductions. Although 98 transduced loci could be uniquely
linked to their source locus and each of them was treated as a
unique group, the remaining 26 transduced loci showed 95%
sequence identity with at least one other transduced locus and
were mapped to the same source locus. Hence, the 26 transduced
loci were assigned to 11 transduction groups, each of which
contained two or more transduced loci.
Seven of the total 109 source loci contained an SVA element
(Fig. 1). These source SVA elements could be unambiguously
identified because only the SVA elements were surrounded by
TSDs. By comparison, in the transduced loci, the TSDs included
both the SVA element and the transduced flanking genomic
sequence. The source SVA element for the transduction group
H3186 located on human chromosome 2p11.2 represented one
of the most active elements we identified, given that it generated
at least nine transduced copies (Fig. 3). Sequence comparisons
showed that the source locus and all nine transduced loci were
absent from the chimpanzee genome. This result suggests that
the source locus inserted in the human genome after the
human–chimpanzee divergence and generated all of the loci with
transductions within the last 6 million years. Among the nine
transduced loci, five were typical SVA transduction loci (i.e.,
having both the SVA element and the transduced sequence),
whereas four loci contained only the transduced genomic se-
quences. Although there is no SVA element upstream of these
sequences, a poly(A) tail can be found downstream of the
transduced sequence, and the TSDs surrounding the transduced
sequence are identifiable. Presumably, these loci were generated
via SVA-mediated transduction events associated with 5 trun-
cation during the integration process or through incomplete
reverse transcription during retrotransposition. SVA represents
one of the most active retrotransposon families in humans (19),
and little is known regarding their retrotransposition mecha-
Fig. 1. Identification of SVA 3 transduction events and their source elements. Shown are the schematic diagrams for the identification process. Flanking
sequences of the source locus are shown as blue boxes; TSDs are shown as yellow and green arrows. SVA elements are depicted as red bars, and the transduced
sequences are shown as blue bars and labeled ‘‘TD.’’ SVA element poly(A) tails are shown as ‘‘(AAA)n.’’ The numbers in parentheses correspond to the total
number of SVA elementsgroups identified in each step.
Fig. 2. Length distribution of 3 transduction events. The number of human
SVA-mediated 3 transduction events in each 100-bp size interval is shown.


















































nism. Because the source loci with SVA elements may be capable
of retrotransposition, detailed analysis of the seven transduction
source loci we identified in this study may shed light on the
underlying mechanism of SVA retrotransposition.
For the other 102 source loci, only sequences corresponding to
transduced sequences were present. Each of the loci was devoid
of the SVA elements, TSDs, and poly(A) tails. The simplest
explanation for this genomic configuration is that the retrotrans-
position events carrying transduced sequence occurred while the
source SVA element was polymorphic for insertion presence
absence in the population. Subsequently, the original locus with
the source SVA element may have been lost in the population or
still may be polymorphic in the human population but absent
from the human genome reference sequence. To test source loci
for insertion polymorphism, we genotyped 30 source loci in 80
diverse human genomes by using PCR assays as described in ref.
17. No source loci containing an SVA element were present in
any of the diverse human genomes that were surveyed for the 30
SVA source elements. These results suggest that most of the
SVA elements that generated transduction events were subse-
quently lost from the human genome. This observation is not
surprising because similar results have been observed in L1-
mediated transduction studies (14, 20). In fact, the majority of
new mobile element insertions are expected to be lost from the
population because of genetic drift under neutral evolution. A
second potential reason for the disappearance of these source
elements may be moderate negative selection as a result of their
transcription and retrotransposition capacity (20).
SVA Transduction-Mediated Gene Duplication. One particularly in-
teresting example of SVA-mediated 3 transduction is the
H1776 group (Fig. 4A), in which four related loci were identified
in the human genome. The source locus (chr17A) contained
only the transduced sequence without the SVA element, and the
other three loci (chr17B, chr18, and chr8) contained an SVA
element along with the transduced sequence resulting from
retrotransposition. This group of transduced sequences is among
the longest of all of the elements we recovered (1,682, 1,245, and
1,257 bp for loci chr17B, chr18, and chr8 respectively). Subse-
quent analysis of the transduced sequences resulted in the
identification of the gene AMAC1 (acyl-malonyl condensing
enzyme 1, Entrez Gene ID: 146861) at the chr17B locus,
AMAC1L1 (AMAC1-like 1, Entrez Gene ID: 492318) at the
chr18 locus, AMAC1L2 (AMAC1-like 2, Entrez Gene ID:
83650) at the chr8 locus, and AMAC1L3 (AMAC1-like 3, Entrez
Gene ID: 404029) at the chr17A locus. Interestingly, the source
locus (chr17A) contains 467 bp of extra sequence in the middle
of the transduced sequence as compared with the other copies.
Examination of the gene structure showed that AMAC1L3 at the
inferred source locus had two exons separated by an intron (the
extra DNA sequence), whereas the three SVA transduced loci
contained intronless versions of AMAC1L3 (Fig. 4A). These
results suggest that the intron was spliced out during the
retrotransposition process, providing further evidence for the
underlying mechanism that created the three duplicated copies
Fig. 3. SVA 3 transduction events. One group of SVA 3 transduction events
(H3186) is shown. Flanking sequences of the original locus are shown as blue
boxes, and the flanking sequences of the transduced loci are shown as light
blue boxes. TSDs are shown as yellow and green arrows. SVA elements are
depicted as red bars, and the transduced sequences are shown as blue bars and
labeled ‘‘TD.’’ SVA element poly(A) tails are shown as ‘‘(AAA)n.’’
Fig. 4. SVA transduction-mediated gene duplication. (A) Schematic diagram of the H1776 transduction group in the human genome. Flanking sequences of
the original locus are shown as blue boxes, and the flanking sequences of the transduced loci are shown as light blue boxes. TSDs are shown as yellow and green
arrows. SVA elements are depicted as red bars, the transduced sequences are shown as blue bars, and coding regions are shown as purple bars. SVA element
poly(A) tails are shown as ‘‘(AAA)n.’’ (B) Schematic diagrams for putative evolutionary scenarios of the SVA transduction-mediated gene duplications.
Approximately 7 million to 14 million years ago, one active SVA element was inserted upstream of the original AMAC gene locus. Then, transcription of this active
SVA element transduced the full-length AMAC gene sequence. During the retrotransposition process, the intron of the gene was removed by RNA processing
machinery. Finally, the SVA element along with the intronless AMAC gene sequence retrotransposed into new genomic locations. The original retrotranspo-
sition-competent SVA element upstream of the source locus was eventually lost in the population. The predicted RNA transcripts are shown as curved lines. (C)
The phylogenetic relationships among various species used in dNdS analysis.




































(Fig. 4B). Although the exact function of human AMAC genes
has not been determined, studies in bacteria showed that AMAC
is an enzyme involved in fatty acid synthesis, in which it
condenses a two-carbon unit from malonyl-(acyl carrier protein)
to fatty acyl-(acyl carrier protein), adding two carbons to the
fatty acid chain with the release of the carbon dioxide (21).
Evolutionary Analyses of AMAC Genes. To determine the evolu-
tionary history of AMAC transduction events, we first used
BLAT to search for orthologous loci corresponding to all four
human AMAC genes in four available mammalian genome
sequences (mouse, rat, cow, and dog). The search resulted in the
identification of a single AMAC locus in all four species exam-
ined, and it was orthologous to the human AMAC1L3. In
particular, the mouse orthologous region is annotated as the
gene AMAC1 (Entrez GeneID: 56293). The murine AMAC1
gene contains two exons similar to human AMAC1L3 gene. Only
the human AMAC1L3 locus was colinear with the mouse
AMAC1 genomic sequence, whereas the three SVA transduced
loci were colinear with the mouse AMAC1 mRNA sequence.
Next, we investigated the origin of the multiple AMAC gene
copies within the primate lineage by analyzing seven nonhuman
primate species (i.e., pygmy chimpanzee, common chimpanzee,
gorilla, orangutan, siamang, African green monkey, and rhesus
monkey). PCR and DNA sequence analyses showed that the
intron-containing locus AMAC1L3 is present in all species
examined. By contrast, the AMAC1 and AMAC1L2 loci were
present only in human, pygmy chimpanzee, common chimpan-
zee, and gorilla genomes. Because of the presence of repetitive
elements in the flanking regions, the AMAC1L1 locus could not
be successfully amplified by using PCR and was excluded from
subsequent analyses. Together, our results suggest that the
transduction events happened after the divergence of African
apes from orangutans but before the divergence of humans,
chimpanzees, and gorillas, 7 to 14 million years ago based on
the estimated divergence time of primates (22).
To determine the functional status of the AMAC genes, we
first examined all available AMAC copies for intact ORFs.
Examination of the DNA sequences showed that the AMAC1
loci in both common chimpanzee and gorilla contained a pre-
mature stop codon in their ORF regions, located at amino acid
positions 29 and 32, respectively. Therefore, these two copies
have lost their coding capacity and have become processed
pseudogenes. The ORFs of all of the other AMAC copies,
including all four human copies, remained intact.
Next, we examined the selective constraints on all AMAC
copies by using the maximum likelihood-based program PAML
(23). PAML estimates the nonsynonymous (dN) and synonymous
(dS) substitution rate ratios (  dNdS) as measures of selective
pressure, where the value of  indicates the type of selection (1,
purifying; 1, neutral; 1, positive). Likelihood ratio tests then
can be used to compare the different models of evolution. First,
a maximum-likelihood tree was constructed by using all available
AMAC ORF sequences (see Materials and Methods), and 
values were estimated according to a model of a single  among
branches of the tree (Model 0) and a model where  is allowed
to vary among branches (Model 1). The results showed that
Model 1 fit the data significantly better than Model 0 (P 
0.0001; see Table 3, which is published as supporting information
on the PNAS web site), suggesting that different selective
pressures are acting on the various AMAC copies within and
between species. We then separated the branches of the tree into
two groups, corresponding to the sequences predating the gene
duplication events (Fig. 4C, black branches) and sequences
postdating duplication events (Fig. 4C, bold blue branches), and
estimated  values for the two groups separately. The  in the
branches predating the duplications was estimated to be 0.13
(significantly different from   1, P  0.0001), suggesting that
the AMAC gene is under strong purifying selection in the species
lacking duplicated copies. By contrast, the  was estimated to be
1.24 (not significantly different from   1, P  0.25) in the
species that possess multiple copies of AMAC. In addition, the
comparison between Model 0 and Model 1 for branches after
the duplications showed that  values among branches are not
significantly different (P  0.69). Together, these results indicate
that the AMAC gene was under purifying selection in all of the
species before the duplication events and that, after the gene
duplication events, all AMAC copies experienced a relaxation of
selective constraints.
These observations are in good agreement with the predic-
tions of classical gene duplication theory (2, 24), which suggests
that the functional redundancy of newly duplicated genes will
result initially in free evolution of all gene copies. The long-term
evolutionary fate of the new gene copies includes loss of function
(nonfunctionalization), evolution of a new function (neofunc-
tionalization), or maintenance of the duplicated copies for the
original function (subfunctionalization). The stop codon present
in different positions in the chimpanzee and gorilla AMAC1
copies shows the nonfunctionalization of these particular gene
copies. Furthermore, we also analyzed the AMAC gene se-
quences for possible sites or domains that are (or were) under
positive selection and developed new functions (neofunctional-
ization) (Table 3 and also Table 4, which is published as
supporting information on the PNAS web site). However, the
paucity of functional studies on the human AMAC genes pre-
vented detailed validation and comparisons of the potential
functional role of candidate sites.
AMAC Expression Studies. To further investigate the functional
status of human AMAC gene duplicates, we examined the
expression pattern of the four human AMAC gene copies.
RT-PCR analysis was performed by using poly(A)-selected RNA
from human testis and placenta and oligonucleotide primers
designed to match conserved regions in all four gene copies (see
Fig. 6, which is published as supporting information on the PNAS
web site). We first amplified the target sequences from human
genomic DNA (HeLa), cloned the PCR products, and sequenced
100 clones. Based on nucleotide substitutions specific for each
AMAC gene duplicate, we determined the origin of each clone.
Our results showed that all four gene copies were recovered in
a comparable manner, showing that our approach amplifies the
four human AMAC copies with similar efficiency (Fig. 5B).
Using the same primer set, RT-PCR generated a product with
the expected size in both tissues (Fig. 5A). We cloned the
RT-PCR products and sequenced 100 clones derived from
each tissue (Fig. 5B). Sequence analysis showed that AMAC1,
AMAC1L2, and AMAC1L3 were expressed in testis, whereas
only AMAC1L2 and AMAC1L3 were expressed in placenta. In
both tissues, the SVA-transduced AMAC1L2 was predominantly
expressed. Together, these results show that at least two SVA-
transduced AMAC gene duplicates are expressed in humans and
that they may have differential tissue expression patterns.
To determine the expression pattern of AMAC gene copies in
human tissues, we searched the National Center for Biotech-
nology Information EST database for AMAC-related tran-
scripts. Consistent with the RT-PCR results, two of the SVA-
transduced AMAC copies (AMAC1 and AMAC1L2) were
recovered from the EST database, and their full-length cDNAs
already have been sequenced (GenBank accession nos.
AK097473 and AJ291677 for AMAC1 and AMAC1L2, respec-
tively). Both mRNA sequences start downstream from the SVA
elements, suggesting that their promoters have been duplicated
along with the gene copies themselves. By contrast, the two
transcripts contained unique 3 UTR sequences specific to their
new genomic locations. Thus, it appears that these two gene


















































copies have acquired new downstream polyadenylation signals
subsequent to their integration in the genome.
Concluding Remarks
Our results represent an example in the primate lineage of gene
duplications derived from SVA-mediated 3 transduction. One
factor that may increase the potency of SVA elements with
regard to the generation of new genes is that, in addition to
duplicating genes, SVA elements also may provide promoters for
newly integrated gene duplicates. SVA elements contain an
LTR-derived region that is used as promoter in endogenous
retroviruses, and several studies have shown that LTRs in the
genome can function as promoters for downstream genes (25,
26). Therefore, the SVA LTR-derived tail region might function
as an alternative promoter for genes involved in 3 transduction
events whenever the original gene-specific promoter was not
transduced.
Retrotransposon-mediated 3 transduction represents a pre-
viously uncharacterized mechanism for entire gene duplication
that can lead to the rapid generation of new gene families.
Although the gene duplications by retrotransposon-mediated
transduction reported here created intronless gene copies similar
to duplications resulting from gene retrotransposition, there is
one major difference between these two duplication mecha-
nisms. Gene retrotransposition generally does not carry the
promoter and regulatory region of the retrotransposed gene to
its new location because of the process by which the gene is
reverse transcribed into cDNA. Thus, the newly transposed gene
must acquire new regulatory sequences to be functional. By
contrast, retrotransposon-mediated 3 transduction events not
only duplicate whole genes, but also can duplicate promoter
regions (as demonstrated by the AMAC gene duplicates). Con-
sequently, duplications resulting from 3 transduction retain
their functional potential after inserting into their new genomic
locations, allowing immediate release of the gene copies (the
original and duplicates) from selective constraints.
Mobile elements already are known for creating genomic
novelty in a variety of ways. For example, L1 elements provide
the molecular machinery necessary for gene retrotransposition
(27, 28), and new fusion genes can be generated during the
process (6, 7). DNA transposons also can mediate exon shuffling
and gene duplication, as demonstrated by mutator-like elements
and helitron-like elements in plants (29, 30). Further, mobile
elements themselves can serve as raw material for the generation
of new functions by their incorporation into existing genes
(31–33). By serving as a mechanism for gene duplication and
generating new gene families, retrotransposon-mediated se-
quence transduction represents an important mechanism by
which mobile elements impact their host genomes.
Materials and Methods
Genome Analysis. The RepeatMasker annotations of the human
genome reference sequence (hg17, May 2004) were obtained
from the University of California, Santa Cruz Genome Bioin-
formatics Site (http:genome.ucsc.edu). The full-length SVA
elements with a 2,000-bp flanking sequence on each side were
exacted by using a perl script, and the TSDs were identified
manually. SVA elements were considered as candidates for
containing 3 transduction sequence if they had (i) unambiguous
TSDs (6 bp) and (ii) a 30-bp sequence between the end of the
SVA sequence and the poly(A) tail immediately upstream of the
3 TSD. The extra sequence then was used for a sequence
similarity BLAT search against the human genomic database.
For genomic loci exhibiting 95% identity to the putative
transduced sequence, a 5-kb extra sequence was extracted on
both ends of the locus, and a locally installed RepeatMasker
program was used to determine their repeat content. In some
cases, segmental duplications may result in a similar pattern as
the 3 transduction. To remove such false-positive hits, we
further compared the sequence directly f lanking the previously
uncharacterized locus with the flanking sequence of the query
locus. If the flanking sequences from both loci showed 90%
sequence similarity for 2 kb in length, the previously unchar-
acterized locus was excluded from the further analysis.
PCRRT-PCR and DNA Sequence Analysis. The human population
panel used in the polymorphism analysis is described in ref. 17.
Other DNA samples used in this study included human genomic
DNA (HeLa cell line ATCC CCL-2) and the following nonhuman
primate species available as a primate phylogenetic panel
PRP00001 from Coriell (Camden, NJ): DNA samples of Pan
troglodytes (common chimpanzee), P. paniscus (bonobo or pygmy
chimpanzee), Gorilla gorilla (western lowland gorilla), Pongo pyg-
maeus (orangutan), and Macaca mulatta (rhesus monkey). DNA
samples of Hylobates syndactylus (siamang) also were purchased
from Coriell (PR00721). DNA samples of Chlorocebus aethiops
(green monkey) were isolated from cell line ATCC CCL70.
The primers and annealing temperatures for each locus are
shown in Table 5, which is published as supporting information
on the PNAS web site, and are also available upon request. For
the AMAC gene analysis, AMAC gene-related loci were ampli-
fied by using PCR with different primates as templates with
different primer sets and annealing temperatures (see Table 6,
Fig. 5. Expression analysis of AMAC gene duplicates in humans. (A) Agarose
gel chromatograph of RT-PCR products derived from human testis (T) and
placental (P) RNA templates. Negative controls with no reverse transcriptase
(RT ) are on the left, a 100-bp marker (M) is in the middle, and reactions with
reverse transcriptase (RT ) are on the right; the sizes of the correct fragments
are indicated. (B) Relative expression levels of four human AMAC gene du-
plicates in human testis and placenta. Human genomic DNA (HeLa) amplifi-
cation is the control for uniform amplification of all gene duplicates.




































which is published as supporting information on the PNAS web
site).
For RT-PCR, 1 g of poly(A)-selected RNA (Ambion, Aus-
tin, TX) from human testis and placenta was used to perform the
reverse transcription reaction by using the Reverse Transcription
System kit (Promega, Madison, WI) with conserved primer 4()
(5-CAGATAGGAAGGCCACTGTTG-3) according to man-
ufacturer’s protocol. After completion, the volume of the reverse
transcription reaction was brought to a final volume of 100 l
with nuclease-free water. Ten microliters of the reverse tran-
scription reaction was used for PCR with conserved primer 1()
(5-ATTGCCCTGCTACTTAAACTGC-3)conserved primer
1() (5-TGTAGTGTCCAGAGTCCAGGTC-3) for 32 cycles
at annealing temperature of 60°C. PCR products were fraction-
ated on a 1.5% low melting agarose gel and extracted with the
QIAquick Gel Extraction kit (Qiagen, Valencia, CA).
For sequencing analysis, individual RT-PCRPCR products
were cloned by using the TOPO-TA cloning kit (Invitrogen,
Carlsbad, Ca) and sequenced by using chain termination se-
quencing on an ABI 3100 Genetic Analyzer (Applied Biosys-
tems, Foster City, CA). All sequences were deposited in Gen-
Bank under accession numbers DQ482900–DQ482914.
Evolutionary Analysis. All available AMAC gene-coding region
homologous sequences were aligned by using ClustalX (34),
followed by manual adjustments. Next, a maximum-likelihood
tree were constructed under HKY85G model by using PAUP*
(35) The resulting tree (see Fig. 7, which is published as
supporting information on the PNAS web site) was used for the
dNdS ratio analysis.
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